Apr 26, 2024 · The induced pluripotent stem cell (iPSC) technology has transformed in vitro research and holds great promise to advance regenerative medicine. iPSCs have the capacity …

Induced pluripotent stem cells (iPSCs) are a new type of pluripotent cells that can be obtained by reprogramming animal and human differentiated cells. In this review, issues related to the …

As iPSCs serve tremendous correction potentials for various diseases, we highlight the successes and challenges of iPSCs in cell replacement therapy and the synergy of iPSCs and clustered …

Extensive research around identifying factors that are involved in maintaining the identity of ESCs during induction of pluripotency in somatic cells is undertaken. The focus of the current review …

Induced pluripotent stem cells (iPSCs) provide a powerful starting material to model human disease in relevant cell types. iPSCs may be generated from patients of any genetic …

Feb 8, 2019 · Enthusiasm for patient-specific therapies based on induced pluripotent stem cells (iPSCs) rose with the rapid advances in precise DNA editing that followed.

We offer media and reagents for each step of the induced pluripotent stem cell (iPSC) workflow: from reprogramming to expansion, validation, and differentiation.

Induced pluripotent stem (iPS) cells, commonly abbreviated as iPS cells or iPSCs, are a type of pluripotent stem cell artificially derived from a non-pluripotent cell, an adult somatic cell, by a …

Induced pluripotent stem (iPS) cells, are a type of pluripotent stem cell derived from adult somatic cells. They have been reprogrammed through inducing genes and factors to be pluripotent. …

Nov 21, 2019 · Induced pluripotent stem cells (iPSCs) are artificial stem cells produced from somatic cells through co-expression of defined pluripotency-associated factors [1, 2].